ESTA Establishment Labs Holdings Inc.
Healthcare$72.64+0.62%ClosedMarket Cap: $2.14B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
144.65
P/S
9.25
EV/EBITDA
-114.03
DCF Value
$-76.16
FCF Yield
-2.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.1%
Operating Margin
-12.4%
Net Margin
-19.1%
ROE
-225.9%
ROA
-12.5%
ROIC
-8.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $59.9M | 70.7% | $-6.5M | $-13.4M | $— | — |
| Q4 null | $64.6M | 70.5% | $-3.9M | $-2.6M | $— | — |
| FY null | $211.1M | 69.3% | $-39.0M | $-51.1M | $— | — |
| Q3 null | $53.8M | 70.1% | $-4.0M | $-11.1M | $— | — |
| Q2 null | $51.3M | 68.8% | $-14.1M | $-16.6M | $— | — |
| Q1 null | $41.4M | 67.2% | $-16.9M | $-20.7M | $— | — |
| Q4 null | $44.5M | 68.5% | $-18.7M | $-34.5M | $— | — |
| FY null | $166.0M | 66.0% | $-50.0M | $-84.6M | $— | — |
| Q3 null | $40.2M | 63.9% | $-13.1M | $-16.7M | $— | — |
| Q2 null | $44.1M | 65.6% | $-9.3M | $-17.2M | $— | — |
| Q1 null | $37.2M | 65.6% | $-8.8M | $-16.2M | $— | — |
| Q4 2023 | $31.6M | 65.2% | $-22.1M | $-20.5M | $-0.79 | — |